Literature DB >> 14728937

The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are. palliative chemotherapy and watchful-waiting.

C G Koedoot1, F J Oort, R J de Haan, P J M Bakker, A de Graeff, J C J M de Haes.   

Abstract

This study aimed to determine the content and the amount of information given by medical oncologists when proposing palliative chemotherapy and whether this information given is influenced by patient or physician background characteristics. In a prospective study, 95 patients with incurable cancer were interviewed before they consulted their medical oncologist. Their first consultation was audiotaped, and their eventual decision scored. A coding scheme comprised six categories of information given during the consultation. Medical oncologists mentioned or explained the disease course (53%), symptoms (35%) and prognosis (39%). Most patients were told about the absence of cure (84%). Watchful-waiting was mentioned to only half of the patients, either in one sentence (23%) or explained more extensively (27%). Multilevel analysis revealed that the patients' age, patient's marital status, and consulting in an academic hospital explained 38% of the amount of information given. Most of the physicians' attention is spent on the 'active' treatment option. Older patients, married patients and patients in academic hospitals receive more information.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14728937     DOI: 10.1016/j.ejca.2003.10.008

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  33 in total

1.  Dying of hematologic patients--treatment characteristics in a German University Hospital.

Authors:  Patrick Brück; Malgorzata Pierzchlewska; Marta Kaluzna-Oleksy; Maria Elizabeth Ramos Lopez; Mathias Rummel; Dieter Hoelzer; Angelika Böhme
Journal:  Support Care Cancer       Date:  2012-03-13       Impact factor: 3.603

Review 2.  Chemotherapy at end-of-life: an integration of oncology and palliative team.

Authors:  Wing-lok Chan; Ka-on Lam; Wai-kwan Siu; Kwok-keung Yuen
Journal:  Support Care Cancer       Date:  2015-11-25       Impact factor: 3.603

Review 3.  The value of progression-free survival to patients with advanced-stage cancer.

Authors:  Lesley J Fallowfield; Anne Fleissig
Journal:  Nat Rev Clin Oncol       Date:  2011-10-18       Impact factor: 66.675

4.  Training for Medical Oncologists on Shared Decision-Making About Palliative Chemotherapy: A Randomized Controlled Trial.

Authors:  Inge Henselmans; Hanneke W M van Laarhoven; Hanneke C J M de Haes; Meltem Tokat; Ellen G Engelhardt; Pomme E A van Maarschalkerweerd; Marleen Kunneman; Petronella B Ottevanger; Serge E Dohmen; Geert-Jan Creemers; Dirkje W Sommeijer; Filip Y F L de Vos; Ellen M A Smets
Journal:  Oncologist       Date:  2018-06-29

5.  Factors impacting on discordance with treatment plan in head and neck cancer patients: a retrospective, population-based cohort study.

Authors:  Ya-Lan Chang; Shu-Chu Lee; Chun-Ta Liao; Chao-Hui Wang; Yu-Fen Lin; Shu-Ching Chen
Journal:  Support Care Cancer       Date:  2019-06-08       Impact factor: 3.603

6.  Obtaining Helpful Information From the Internet About Prognosis in Advanced Cancer.

Authors:  Ivan Chik; Thomas J Smith
Journal:  J Oncol Pract       Date:  2015-07       Impact factor: 3.840

7.  Association of patient-provider communication domains with lung cancer treatment.

Authors:  Jenny J Lin; Jessica Lake; Melanie M Wall; Andrew R Berman; John Salazar-Schicchi; Charles Powell; Steven M Keller; Ethan A Halm; Howard Leventhal; Juan P Wisnivesky
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

8.  Effect of a Skills Training for Oncologists and a Patient Communication Aid on Shared Decision Making About Palliative Systemic Treatment: A Randomized Clinical Trial.

Authors:  Inge Henselmans; Hanneke W M van Laarhoven; Pomme van Maarschalkerweerd; Hanneke C J M de Haes; Marcel G W Dijkgraaf; Dirkje W Sommeijer; Petronella B Ottevanger; Helle-Brit Fiebrich; Serge Dohmen; Geert-Jan Creemers; Filip Y F L de Vos; Ellen M A Smets
Journal:  Oncologist       Date:  2019-11-26

9.  The lack of standard definitions in the supportive and palliative oncology literature.

Authors:  David Hui; Masanori Mori; Henrique A Parsons; Sun Hyun Kim; Zhijun Li; Shamsha Damani; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2011-11-21       Impact factor: 3.612

10.  "Well, I think there is great variation...": a qualitative study of oncologists' experiences and views regarding medical criteria and other factors relevant to treatment decisions in advanced cancer.

Authors:  Jan Schildmann; Jacinta Tan; Sabine Salloch; Jochen Vollmann
Journal:  Oncologist       Date:  2013-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.